Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B

Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B

10.1016/j.jhep.2008.12.019

Saved in:
Bibliographic Details
Main Authors: Zeuzem, S., Gane, E., Liaw, Y.-F., Lim, S.G., DiBisceglie, A., Buti, M., Chutaputti, A., Rasenack, J., Hou, J., O'Brien, C., Nguyen, T.T., Jia, J., Poynard, T., Belanger, B., Bao, W., Naoumov, N.V.
Other Authors: MEDICINE
Format: Article
Published: 2016
Subjects:
Chronic hepatitis B
GLOBE trial
Lamivudine
Predictors
Telbivudine
Online Access:http://scholarbank.nus.edu.sg/handle/10635/129754
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore

Internet

http://scholarbank.nus.edu.sg/handle/10635/129754

Similar Items